JP2005521639A5 - - Google Patents

Download PDF

Info

Publication number
JP2005521639A5
JP2005521639A5 JP2003543536A JP2003543536A JP2005521639A5 JP 2005521639 A5 JP2005521639 A5 JP 2005521639A5 JP 2003543536 A JP2003543536 A JP 2003543536A JP 2003543536 A JP2003543536 A JP 2003543536A JP 2005521639 A5 JP2005521639 A5 JP 2005521639A5
Authority
JP
Japan
Prior art keywords
cyanomethyl
trans
cyclohexanecarboxamide
methyl
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003543536A
Other languages
English (en)
Japanese (ja)
Other versions
JP4343690B2 (ja
JP2005521639A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/036352 external-priority patent/WO2003041649A2/en
Publication of JP2005521639A publication Critical patent/JP2005521639A/ja
Publication of JP2005521639A5 publication Critical patent/JP2005521639A5/ja
Application granted granted Critical
Publication of JP4343690B2 publication Critical patent/JP4343690B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003543536A 2001-11-13 2002-11-13 プロテアーゼ阻害薬としてのシアノアルキルアミノ誘導体 Expired - Fee Related JP4343690B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35131601P 2001-11-13 2001-11-13
PCT/US2002/036352 WO2003041649A2 (en) 2001-11-13 2002-11-13 Cyanoalkylamino derivatives as protease inhibitors

Publications (3)

Publication Number Publication Date
JP2005521639A JP2005521639A (ja) 2005-07-21
JP2005521639A5 true JP2005521639A5 (https=) 2009-03-26
JP4343690B2 JP4343690B2 (ja) 2009-10-14

Family

ID=23380408

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003543536A Expired - Fee Related JP4343690B2 (ja) 2001-11-13 2002-11-13 プロテアーゼ阻害薬としてのシアノアルキルアミノ誘導体

Country Status (8)

Country Link
US (1) US7371747B2 (https=)
EP (1) EP1446115B1 (https=)
JP (1) JP4343690B2 (https=)
AT (1) ATE387197T1 (https=)
AU (1) AU2002352663B2 (https=)
CA (1) CA2466115A1 (https=)
DE (1) DE60225316T2 (https=)
WO (1) WO2003041649A2 (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759428B2 (en) 2001-12-04 2004-07-06 Roche Palo Alto Llc Indole nitriles
JP2005517640A (ja) 2001-12-04 2005-06-16 エフ.ホフマン−ラ ロシュ アーゲー 置換2−アミノ−シクロアルカンカルボキサアミドならびにシステインプロテアーゼインヒビターとしてのその使用
US7375134B2 (en) * 2002-03-05 2008-05-20 Axys Pharmaceuticals, Inc. Cathepsin cysteine protease inhibitors
WO2003099284A1 (en) 2002-05-22 2003-12-04 Amgen Inc. Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
BR0313255A (pt) 2002-08-08 2005-07-12 Amgen Inc Composto, composição farmacêutica, uso de um composto e métodos de fabricar um medicamento e de preparar um composto
KR20080103117A (ko) 2002-09-24 2008-11-26 노파르티스 아게 탈수초성 장애의 치료에 있어서의 스핑고신-1-포스페이트 수용체 아고니스트
WO2004108661A1 (en) * 2003-06-04 2004-12-16 Axys Pharmaceuticals Amidino compounds as cysteine protease inhibitors
WO2005000800A1 (en) * 2003-06-30 2005-01-06 Merck Frosst Canada Ltd. Cathepsin cysteine protease inhibitors
TW200510436A (en) * 2003-07-21 2005-03-16 Novartis Ag Combinations of a cathepsin k inhibitor and a bisphosphonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss
AU2004266740B2 (en) * 2003-08-21 2010-08-26 Merck Frosst Canada Ltd Cathepsin cysteine protease inhibitors
DK1663958T3 (da) * 2003-09-18 2015-04-07 Virobay Inc Haloalkylholdige forbindelser som cysteinproteasehæmmere
MY139645A (en) 2004-02-11 2009-10-30 Amgen Inc Vanilloid receptor ligands and their use in treatments
JP2007522233A (ja) 2004-02-11 2007-08-09 アムジエン・インコーポレーテツド バニロイド受容体リガンド及び治療におけるそれらの使用
AR055283A1 (es) * 2004-11-23 2007-08-15 Merck Frosst Canada Ltd Inhibidores de cisteinproteasa de catepsina
WO2006060810A1 (en) * 2004-12-02 2006-06-08 Schering Aktiengesellschaft Sulfonamide compounds as cysteine protease inhibitors
WO2006089311A1 (en) 2005-02-15 2006-08-24 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US7488848B2 (en) * 2005-03-21 2009-02-10 Virobay, Inc. Alpha ketoamide compounds as cysteine protease inhibitors
JP5215167B2 (ja) * 2005-03-22 2013-06-19 ビロベイ,インコーポレイティド システインプロテアーゼ阻害剤としてのスルホニル基含有化合物
JP5122447B2 (ja) * 2005-07-06 2013-01-16 メルク カナダ インコーポレイテッド カテプシンシステインプロテアーゼ阻害剤
EP2079683B1 (en) * 2006-10-04 2015-01-21 Virobay, Inc. Di-fluoro containing compounds as cysteine protease inhibitors
US7893112B2 (en) * 2006-10-04 2011-02-22 Virobay, Inc. Di-fluoro containing compounds as cysteine protease inhibitors
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
EP2719700A1 (en) 2008-01-09 2014-04-16 Amura Therapeutics Limited Tetrahydrofuro(3,2-b)pyrrol-3-one derivatives as inhibitors of cysteine proteinases
KR20110020928A (ko) 2008-06-20 2011-03-03 노파르티스 아게 다발성 경화증을 치료하기 위한 소아용 조성물
NZ602832A (en) 2008-07-14 2014-04-30 Gilead Sciences Inc Fused heterocyclic hdac inhibitor compounds
WO2010009166A1 (en) 2008-07-14 2010-01-21 Gilead Colorado, Inc. Oxindolyl inhibitor compounds
JP5640005B2 (ja) 2008-07-14 2014-12-10 ギリアード サイエンシーズ, インコーポレイテッド Hdacおよび/またはcdk阻害剤としてのイミダゾシルピリジン化合物
JP2011529504A (ja) 2008-07-28 2011-12-08 ギリアード サイエンシーズ, インコーポレイテッド シクロアルキリデンヒストン脱アセチル化酵素阻害剤化合物およびヘテロシクロアルキリデンヒストン脱アセチル化酵素阻害剤化合物
WO2010144378A2 (en) 2009-06-08 2010-12-16 Gilead Colorado, Inc. Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
KR20120031170A (ko) 2009-06-08 2012-03-30 길리애드 사이언시즈, 인코포레이티드 알카노일아미노 벤즈아미드 아닐린 hdac 저해제 화합물
US7893099B2 (en) * 2009-06-11 2011-02-22 Hoffman-La Roche Inc. Cyclopentane derivatives
US8324417B2 (en) * 2009-08-19 2012-12-04 Virobay, Inc. Process for the preparation of (S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
MX353408B (es) 2010-04-22 2018-01-11 Vertex Pharma Proceso para producir compuestos de cicloalquilcarboxamido-indol.
AU2013250726B2 (en) 2012-04-20 2017-01-05 Advinus Therapeutics Limited Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof
US9617259B2 (en) * 2013-03-14 2017-04-11 Chdi Foundation, Inc. Histone deacetylase inhibitors and compositions and methods of use thereof
CN103275034B (zh) * 2013-04-16 2015-07-08 南京工业大学 一类小分子cathepsin D抑制剂的制备方法
RU2744460C2 (ru) 2014-04-15 2021-03-09 Вертекс Фармасьютикалз Инкорпорейтед Фармацевтические композиции для лечения заболеваний, опосредованных муковисцидозным трансмембранным регулятором проводимости
AU2021224588B2 (en) 2020-02-18 2024-07-18 Gilead Sciences, Inc. Antiviral compounds
TWI775313B (zh) 2020-02-18 2022-08-21 美商基利科學股份有限公司 抗病毒化合物
TWI794742B (zh) 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
EP4323362B1 (en) 2021-04-16 2025-05-07 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides
AU2022328698B2 (en) 2021-08-18 2025-02-20 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0313847A3 (en) * 1987-10-01 1989-11-29 G.D. Searle & Co. Non-peptidyl alpha-succinamidoacyl aminodiols as anti-hypertensive agents
CN1362947A (zh) 1999-03-15 2002-08-07 Axys药物公司 用作蛋白酶抑制剂的n-氰基甲基酰胺

Similar Documents

Publication Publication Date Title
JP2005521639A5 (https=)
US10214477B2 (en) (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
JP2010504342A5 (https=)
US7897623B2 (en) ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors
HRP20140105T1 (hr) Novi inhibitori seh i njihova upotreba
JP2021515004A5 (https=)
US20040147745A1 (en) Novel compounds and compositions as protease inhibitors
US7371747B2 (en) Cyanoalkylamino derivatives as protease inhibitors
HRP20130220T1 (hr) Modulatori indolamin 2,3-dioksigenaze i postupci upotrebe istih
AR048306A1 (es) Derivados de acidos carboxilicos aromaticos con capacidad moduladora de los niveles de insulina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastornos metabolicos que responden a la regulacion de gpr40
RU2012129737A (ru) Замещенные бензамидные производные
RU2007119427A (ru) Соединения, являющиеся ингибиторами гликогенфосфорилазы, и фармацевтические композиции на их основе
RU2012145298A (ru) Средства, индуцирующие апоптоз, для лечения рака, иммунных и аутоиммунных заболеваний
US20040014796A1 (en) Novel compounds and compositions as cathepsin S inhititors
HRP20140970T1 (hr) Spoj azolkarboksamida ili njegova sol
CA2482346A1 (en) Substituted phenylacetamides and their use as glucokinase activators
AR042342A1 (es) Derivados de pirazina que presentan efecto inhibidor selectivo sobre gsk3, proceso de preparacion y formulaciones farmaceuticas que los contienen
CA2504207A1 (en) New amide compounds having mch-antagonistic activity and medicaments comprising these compounds
NZ332478A (en) Use of collagenase-3 selective inhibitors for treating joint diseases
JP2011511781A (ja) プロスタグランジンd2受容体のn,n−2置換アミノアルキルビフェニルアンタゴニスト
JP2015502335A5 (https=)
JP2004529931A5 (https=)
JP2008519761A5 (https=)
RU2015113746A (ru) Замещенные сульфонамиды
JP2004504400A5 (https=)